Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with the typical form of Parkinson's Disease at a moderate to more advanced stage (Hoehn-Yahr stage II–IV) who are already receiving standard treatment
- People experiencing serious walking and movement difficulties, such as balance problems and/or "freezing" episodes (where movement suddenly stops), even with the best available medication
- People aged 18 or older
- People who are able to communicate with the study team in French or English
- Women who are able to become pregnant and are willing to use reliable contraception throughout the study
- People who agree to follow all study conditions, attend all required visits and training sessions, and sign a consent form before any study activities begin
Who may not be able to join:
- People with atypical forms of Parkinson's Disease, such as Multiple System Atrophy or Progressive Supranuclear Palsy
- People whose walking difficulties are caused by a condition other than Parkinson's Disease
- People who are unable to follow the study procedures
- People with an unstable or serious health condition that the study investigator believes could interfere with the study or affect the results
- People with a significant history of major psychiatric illness or serious cognitive (thinking and memory) problems, as assessed by the study investigators together with the treating doctor and neurologist
- People who have a major change in their Parkinson's treatment planned before the end of the main study phase, such as deep brain stimulation surgery or a dopamine pump implant
- People with health conditions that would make implantation surgery riskier
- People with spinal abnormalities that would make surgery not possible
- People with a history of drug or alcohol misuse in the past 5 years
- People with a life expectancy of less than 12 months
- People who are pregnant or breastfeeding
- People who plan to become pregnant during the study
- People who require frequent MRI scans for another medical reason
- People who have taken part in an experimental treatment in the past 5 years
- People who are currently participating in another interventional study
- The study investigator, their family members, employees, or other people who depend on them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jocelyne Bloch, MD, Centre hospitalier universitaire vaudois (CHUV)
Phone: +41 79 556 29 51
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of serious adverse events and adverse events that are deemed related or possibly related to the study procedures or to the investigational system.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.